| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Real Estate > Buyers Market or a Sellers Market? How to Identify What Kind of Real Estate Market You're In |
|
Answers - Buyers Market or a Sellers Market? How to Identify What Kind of Real Estate Market You're In
If you’re planning on buying or selling a home in any market, it is to your advantage to know the curre According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nt trends. I’ve heard people claim that you can tell that the housing market is softening because ther ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in are 20% more homes on the market now, compared to the same time last year. That is not necessarily tr lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e because it only looks at supply. Certainly a rise in supply could lead to a softening market. Howe here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe er, the fact of the matter is that, if at the same time there’s 100% more buyers now, compared to the s d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro me time last year, the market is hardly softening. Economics 101 teaches that in order to find the equ ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc librium to determine price and quantity, we need to know supply AND demand. Unfortunately, the amount easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi of homes on the market now, compared to one year ago, only looks at supply. In order to truly understa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically d what kind of market we’re currently in, we need to know demand. To do this, I look at “months suppl and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ .” What is months supply? Basically, months supply is the ratio of inventory to sales. And what it t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi lls us is how many months the stock of homes for sale would last, if sales continued at their current r ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a te. For those of us that need to see a formula: # of homes for sale on the market -------------- dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod -------------------------- = Months Supply # of homes sold that month *important note - if your d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ta for number of homes sold is for a period other than one month, remember to take a monthly average. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Its months supply, not 2 months supply. What do the numbers mean? For some reference, in the ’89 US h t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel using market (buyers market) saw around 7 months supply. For those of us who are more familiar with m ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust re recent years, in ’01 the US average was slightly below 4 months supply. But hot markets like Las Ve y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products as, Boston, and parts of Florida and California should have seen below 2 months supply in recent years. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de So anywhere around 4-5 months supply is roughly average. The further your numbers stray below that, m elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ans it’s more of a sellers market. The higher the number is, then the more the market favors the buyer tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Credit Repair Book - Get One Right Here
|